Study limitations
The present study is a proof-of-concept study aimed at validating a potential application of our previous observation regarding the short-term kinetics of NTproBNP in patients with recent-onset AF. No clinical outcomes were evaluated and thus no specific recommendations regarding the clinical practice of management of patients with AF can be made on the basis of these findings.